Impacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombia

Vista sencilla de ítem
dc.contributor.advisorNavarro Rubiano, Margarita
dc.contributor.advisorCastellanos Domínguez, Yeny Zulay
dc.contributor.apolounabNavarro Rubiano, Margarita [margarita-navarro-rubiano]spa
dc.contributor.apolounabCastellanos Domínguez, Yeny Zulay [yeny-zulay-castellanos-domínguez]spa
dc.contributor.authorZúniga Sierra, Eduardo Antonio
dc.contributor.cvlacNavarro Rubiano, Margarita [0001674101]spa
dc.contributor.cvlacCastellanos Domínguez, Yeny Zulay [0001363740]spa
dc.contributor.orcidCastellanos Domínguez, Yeny Zulay [0000-0001-5881-1998]spa
dc.contributor.researchgateCastellanos Domínguez, Yeny Zulay [Yeny-Castellanos-2]spa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.coverage.spatialBucaramanga (Santander, Colombia)spa
dc.coverage.temporalEnero de 2021 a mayo de 2022spa
dc.date.accessioned2023-08-09T18:34:55Z
dc.date.available2023-08-09T18:34:55Z
dc.date.issued2023-08-04
dc.degree.nameEspecialista en Ginecología y Obstetriciaspa
dc.description.abstractEl objetivo principal de este estudio es conocer el impacto del uso de un medio audiovisual en la percepción sobre el uso del dispositivo intrauterino tipo T de cobre (DIU-Cu) en mujeres mayores de 18 años que se encuentren en las primeras 48 horas de parto vaginal en el hospital Local del Norte, se seleccionaron y encuestaron un total de 233 mujeres entre 18-44 años, encontrando que los resultados de este estudio sugieren que el uso de un medio audiovisual puede ser una estrategia efectiva para mejorar la percepción y el conocimiento del DIU-Cu como método anticonceptivo en mujeres en puerperio inmediato de parto vaginal.spa
dc.description.abstractenglishThe main objective of this study is to know the impact of the use of an audiovisual media on the perception of the use of the copper intrauterine device in women over 18 years of age who are in the first 48 hours of vaginal delivery at the Local del Norte hospital, a total of 233 women between 18-44 years of age were selected and surveyed, finding that the results of this study suggest that the use of an audiovisual media can be an effective strategy to improve perception and knowledge of the copper IUD as a contraceptive method in women in the immediate postpartum period after vaginal delivery.spa
dc.description.degreelevelEspecializaciónspa
dc.description.learningmodalityModalidad Presencialspa
dc.description.tableofcontents1. RESUMEN......................................................................................................................................... 4 2. PLANTEAMIENTO DEL PROBLEMA DE INVESTIGACIÓN Y JUSTIFICACIÓN............................... 5 2.1 Pregunta de investigación........................................................................................................... 10 3. MARCO TEÓRICO ............................................................................................................................ 10 3.1 Definiciones ................................................................................................................................... 10 3.2. Intervenciones educativas para promover la planificación familiar .................................... 12 3.3 Métodos disponibles en la planificación posparto .................................................................. 16 3.4 Importancia del DIU posparto comparado con otros métodos de planificación................. 21 3.5 Historia de los Dispositivos Intrauterinos.................................................................................. 22 3.6 Técnica de inserción del DIU T de cobre ................................................................................... 23 3.7 Momento de la inserción ............................................................................................................. 24 3.8 Complicaciones y tasas de expulsión del DIU en el posparto ................................................ 26 3.9 Seguimiento posterior a inserción del dispositivo intrauterino T de cobre ......................... 26 3.10 Contraindicaciones para el uso de dispositivo intrauterino T de cobre en el posparto.... 27 4. ESTADO DEL ARTE ........................................................................................................................... 28 5. OBJETIVOS ........................................................................................................................................ 37 5.1 General ........................................................................................................................................... 37 5.2 Específicos ..................................................................................................................................... 38 6.METODOLOGÍA................................................................................................................................. 38 6.1 Tipo y diseño de estudio ............................................................................................................. 38 6.2 Hipótesis......................................................................................................................................... 38 6.3 Ubicación espacio temporal ....................................................................................................... 38 6.4 Población blanco........................................................................................................................... 39 6.5 Criterios de selección................................................................................................................... 39 6.6 Tamaño de la muestra y muestreo............................................................................................ 39 6.7 Intervención (Medio audiovisual)............................................................................................... 40 6.8 Instrumento de recolección ....................................................................................................... 40 6.9 Variables......................................................................................................................................... 41 6.10 Procedimiento del estudio........................................................................................................ 41 6.11 Plan de análisis........................................................................................................................... 42 7. CONTROL DE SESGO...................................................................................................................... 42 8.CONSIDERACIONES ÉTICAS............................................................................................................ 43 9. RESULTADOS .................................................................................................................................. 44 9.1 Análisis univariado ...................................................................................................................... 44 9.2 Análisis de la intervención.......................................................................................................... 49 9.3 Análisis bivariado......................................................................................................................... 55 9.4 Análisis multivariado ................................................................................................................... 61 10. DISCUSIÓN .................................................................................................................................... 62 11. CONCLUSIONES ........................................................................................................................... 66 12. FORTALEZAS Y LIMITACIONES ................................................................................................... 67 13. APORTES DEL ESTUDIO............................................................................................................... 68 14. REFERENCIAS ............................................................................................................................... 70 15. ANEXOS......................................................................................................................................... 79spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/21121
dc.language.isospaspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.publisher.programEspecialización en Ginecología y Obstetriciaspa
dc.relation.referencesUnited Nations. Contraceptive Use by Method 2019. Contraceptive Use by Method 2019. 2019spa
dc.relation.referencesSilva-Filho AL da, Lira J, Rocha ALL, Ferreira MCF, Lamaita RM, Cândido EB, et al. Non-hormonal and hormonal intrauterine contraception: survey of patients’ perceptions in four Latin American countries. European Journal of Contraception and Reproductive Health Care. 2016;21(3):213–9.spa
dc.relation.referencesCommittee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug 1;128(2):e32–7.spa
dc.relation.referencesMinisterio de Salud y Protección Social. Encuesta Nacional de Demografía y Salud Colombia 2015. Resumen ejecutivo. Semarnat. 2017;1–96.spa
dc.relation.referencesMinisterio de salud y proteccion social, profamilia. Encuesta Nacional de Demografía y Salud Encuesta Nacional de Demografía y Salud Componente de Salud Sexual y Salud Reproductiva. 2015.spa
dc.relation.referencesWHO. Estrategias para la Programación de la Planificación Familiar Posparto. Geneva: World Health Organization; 2014. p. 58.spa
dc.relation.referencesWilliams HR, Goad L, Treloar M, Ryken K, Mejia R, Zimmerman MB, et al. Confidence and readiness to discuss, plan and implement postpartum contraception during prenatal care versus after delivery. J Obstet Gynaecol (Lahore). 2019;39(7):941–7.spa
dc.relation.referencesWHO. Report of a WHO Technical Consultation on Birth Spacing. Report of a WHO Technical Consultation on Birth Spacing. 2005;13(6):1–44.spa
dc.relation.referencesWho, Unicef, Unfpa TWBank. Maternal Mortality in 2005: estimates developed by WHO, UNICEF, UNFPA and The World Bank. Bull World Health Organ. 2007;79:657–64.spa
dc.relation.referencesSaeed GA, Fakhar S, Rahim F, Tabassum S. Change in trend of contraceptive uptake - effect of educational leaflets and counseling. Contraception. 2008;77(5):377–81.spa
dc.relation.referencesCanning D, Shah IH, Pearson E, Pradhan E, Karra M, Senderowicz L, et al. Institutionalizing postpartum intrauterine device (IUD) services in Sri Lanka, Tanzania, and Nepal: study protocol for a cluster-randomized stepped-wedge trial. BMC Pregnancy Childbirth. 2016 Dec 21;16(1):362.spa
dc.relation.referencesGómez Sánchez PI. Anticoncepción. Pasado, presente y futuro. Bogotá: Universidad Nacional Sede Bogotá; 2010. 43–45 p.spa
dc.relation.referencesAlkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: A systematic and comprehensive analysis. The Lancet. 2013;381(9878):1642–52.spa
dc.relation.referencesAhmed S, Choi Y, Rimon JG, Alzouma S, Gichangi P, Guiella G, et al. Trends in contraceptive prevalence rates in sub-Saharan Africa since the 2012 London Summit on Family Planning: results from repeated cross-sectional surveys. Lancet Glob Health. 2019;7(7):e904–11.spa
dc.relation.referencesUnited Nations. World Family Planning 2022 Meeting the changing needs for family planning: Contraceptive use by age and method. Nueva York; 2022.spa
dc.relation.referencesMoore Z, Pfitzer A, Gubin R, Charurat E, Elliott L, Croft T. Missed opportunities for family planning: An analysis of pregnancy risk and contraceptive method use among postpartum women in 21 low- and middle-income countries. Contraception. 2015;92(1):31–9.spa
dc.relation.referencesKeogh SC, Urassa M, Kumogola Y, Kalongoji S, Kimaro D, Zaba B. Postpartum Contraception in Northern Tanzania: Patterns of Use, Relationship to Antenatal Intentions, and Impact of Antenatal Counseling. Stud Fam Plann. 2015;46(4):405–22.spa
dc.relation.referencesZimmerman LA, Yi Y, Yihdego M, Abrha S, Shiferaw S, Seme A, et al. Effect of integrating maternal health services and family planning services on postpartum family planning behavior in Ethiopia: Results from a longitudinal survey. BMC Public Health. 2019;19(1):1–9.spa
dc.relation.referencesDev R, Kohler P, Feder M, Unger JA, Woods NF, Drake AL. A systematic review and meta-analysis of postpartum contraceptive use among women in low- And middle-income countries. Reprod Health. 2019;16(1):1–17.spa
dc.relation.referencesVernon R. Meeting the Family Postpartum Planning Women. Stud Fam Plann. 2012;40(3):235–45.spa
dc.relation.referencesCwiak C, Gellasch T, Zieman M. Peripartum contraceptive attitudes and practices. Contraception. 2004;70(5):383–6.spa
dc.relation.referencesDEHLENDORF C, KRAJEWSKI C, BORRERO S. 14. Contraceptive Counseling: Best Practices to Ensure Quality Communication and Enable Effective Contraceptive Use. Clin Obstet Gynecol. 2014;57(4):659–73.spa
dc.relation.referencesNicolaides KH. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy. The American College of Obstetricians and Gynecologist. 2017;701(698):1–4.spa
dc.relation.referencesMINISTERIO DE SALUD Y PROTECCIÓN SOCIAL. RESOLUCIÓN NÚMERO 3280 DE 2018. 2018.spa
dc.relation.referencesCommittee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug 1;128(2):e32–7.spa
dc.relation.referencesDehlendorf C, Fitzpatrick J, Steinauer J, Swiader L, Grumbach K, Hall C, et al. Development and field testing of a decision support tool to facilitate shared decision making in contraceptive counseling. Patient Educ Couns. 2017;100(7):1374–81.spa
dc.relation.referencesCunningham, F. Gary ; Leveno, Kenneth J.; Bloom, Steven L.; Dashe, Jodi S.; Hoffman, Barbara L.; Casey, Brian M.; Spong CY. Williams OBSTETRICIA. McGraw Hill Education; 2019.spa
dc.relation.referencesWHO. WHO Technical Consultation on Postpartum and Postnatal Care. 2010. p. 65.spa
dc.relation.referencesMoore AM, Dauphinee LA. Reasons U . S . Women Have Abortions : Quantitative and Qualitative Perspectives. Perspect Sex Reprod Health. 2005;37(3):110–8.spa
dc.relation.referencesAnne Nordal Broen, M.D.*, Torbjfrn Moum PhD, Anne Sejersted Bfdtker, M.D., O ̈ ivind Ekeberg, M.D. PhD. Reasons for induced abortion and their relation to women ’ s emotional distress : a prospective , two-year follow-up study. Gen Hosp Psychiatry. 2005;27(1):36–43.spa
dc.relation.referencesSOBER S, SCHREIBER CA. Postpartum Contraception. Clin Obstet Gynecol. 2014;57(4):763–76.spa
dc.relation.referencesUSAID, Johns Hopkins Bloomberg School of Public Health and Center For Communication Program, World Health Organization. Family Planning. A Global Handbook for Providers. 2018. 2018.spa
dc.relation.referencesLester F, Kakaire O, Byamugisha J, Averbach S, Fortin J, Maurer R, et al. Intracesarean insertion of the Copper T380A versus 6 weeks postcesarean: A randomized clinical trial. Contraception. 2015;91(3):198–203.spa
dc.relation.referencesWHO. Implementation Guide For The Medical Eligibility Criteria For Contraceptive Use And Selected Practice Recommendations For Contraceptive Use Guidelines. 2018.spa
dc.relation.referencesReport MW. U . S . Medical Eligibility Criteria for Contraceptive Use , 2016. Vol. 65. 2016.spa
dc.relation.referencesWHO. The ABC’s of Family Planning. 2010.spa
dc.relation.referencesCleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Sexual and Reproductive Health 3 Family planning : the unfi nished agenda. 2006;368.spa
dc.relation.referencesTitilope Oduyebo, MD, MPH; Lauren B. Zapata, PhD; Maegan E. Boutot, MS; Naomi K. Tepper, MD M, Kathryn M. Curtis, PhD; Denise V. D’Angelo, MPH; Polly A. Marchbanks, PhD; Maura K. Whiteman P, Marchbanks PA, Whiteman MK. Factors associated with postpartum use of long-acting reversible contraception. The American Journal of Obstetrics & Gynecology. 2019;221(1):43.e1-43.e11.spa
dc.relation.referencesOddens BJ. DETERMINANTS OF CONTRACEPTIVE USE AMONG WOMEN OF REPRODUCTIVE AGE IN GREAT BRITAIN AND GERMANY II : PSYCHOLOGICAL FACTORS. J biosoc Sci. 1997;437–70.spa
dc.relation.referencesBelfield T, Ffsrh H. Best Practice & Research Clinical Obstetrics and Gynaecology Principles of contraceptive care : choice , acceptability and access. Best Pract Res Clin Obstet Gynaecol. 2009;23(2):177–85.spa
dc.relation.referencesWellings K, Zhihong Z, Krentel A, Barrett G, Glasier A. Attitudes towards long- acting reversible methods of contraception in general practice in the UK. 2007;76:208–14.spa
dc.relation.referencesHersh AR, Muñoz LF, Rincón M, Alvarez C, Tolosa JE, Moreno DJ, et al. Video compared to conversational contraceptive counseling during labor and maternity hospitalization in Colombia: A randomized trial. Contraception. 2018 Sep;98(3):210–4.spa
dc.relation.referencesHebert LE, Hill BJ, Quinn M, Holl JL, Whitaker AK, Gilliam ML. Mobile contraceptive application use in a clinical setting in addition to standard contraceptive counseling: A randomized controlled trial. Contraception. 2018;98(4):281–7.spa
dc.relation.referencesLohr PA, Aiken ARA, Forsyth T, Trussell J. Telephone or integrated contraception counselling before abortion: Impact on method choice and receipt. BMJ Sex Reprod Health. 2018;44(2):114–21.spa
dc.relation.referencesKoo HP, Wilson EK, Minnis AM. A Computerized Family Planning Counseling Aid: A Pilot Study Evaluation of Smart Choices. Perspect Sex Reprod Health. 2017;49(1):45–53.spa
dc.relation.referencesSapkota S, Rajbhandary R, Lohani S. The Impact of Balanced Counseling on Contraceptive Method Choice and Determinants of Long Acting and Reversible Contraceptive Continuation in Nepal. Matern Child Health J. 2017;21(9):1713–23.spa
dc.relation.referencesSridhar A, Chen A, Forbes ER, Glik D. Mobile application for information on reversible contraception: A randomized controlled trial. Am J Obstet Gynecol. 2015;212(6):774.e1-774.e7.spa
dc.relation.referencesGeorge T, DeCristofaro C, Dumas B, Murphy P. Shared Decision Aids: Increasing Patient Acceptance of Long-Acting Reversible Contraception. Healthcare. 2015;3(2):205–18.spa
dc.relation.referencesFarrokh-Eslamlou H, Aghlmand S, Eslami M, Homer CSE. Impact of the World Health Organization’s decision-making tool for family planning clients and providers on the quality of family planning services in Iran. Journal of Family Planning and Reproductive Health Care. 2014;40(2):89–95.spa
dc.relation.referencesCastaño PM, Bynum JY, Andrés R, Lara M, Westhoff C. Effect of daily text messages on oral contraceptive continuation: A randomized controlled trial. Obstetrics and Gynecology. 2012;119(1):14–20.spa
dc.relation.referencesColeman-Minahan K, Potter JE. Quality of postpartum contraceptive counseling and changes in contraceptive method preferences. Contraception. 2019;100(6):492–7.spa
dc.relation.referencesTaub RL, Jensen JT. Advances in contraception: new options for postpartum women. Expert Opin Pharmacother. 2017;18(7):677–88.spa
dc.relation.referencesDelvoye P, Demaegd M, Uwayitu-Nyampeta, Robyn C. Serum prolactin, gonadotropins, and estradiol in menstruating and amenorrheic mothers during two years’ lactation. Am J Obstet Gynecol. 1978;130(6):635–9.spa
dc.relation.referencesVan der Wijden C, Brown J, Kleijnen J. Lactational amenorrhea for family planning. Cochrane Database of Systematic Reviews. 2003;(4).spa
dc.relation.referencesMeng K, Hu X, Peng X, Zhang Z. Incidence of venous thromboembolism during pregnancy and the puerperium: A systematic review and meta-analysis. Journal of Maternal-Fetal and Neonatal Medicine. 2015;28(3):245–53.spa
dc.relation.referencesPoulter NR, Meirik O. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: Results of an international multicenter, case-control study. Contraception. 1998;57(5 SUPPL.):315–24.spa
dc.relation.referencesSimmons KB, Edelman AB, Li H, Yanit KE, Jensen JT. Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: A randomized, controlled trial. Contraception. 2013;88(1):45–51.spa
dc.relation.referencesFda. NEXPLANON (etonogestrel implant) IMPLANON (etonogestrel implant).spa
dc.relation.referencesFECOLSOG. FECOLSOG. 2017. Anticoncepción Post Evento de Morbilidad Materna Extrema Anticoncepción Post Evento de Morbilidad. Available from: https://fecolsog.org/articulos-noticias/anticoncepcion-post-evento-de- morbilidad-materna-extrema/spa
dc.relation.referencesFda. JADELLE (levonorgestrel implants) for subdermal use.spa
dc.relation.referencesUNDP/UNFPA/WHO/World Bank Special Programme of Research D and RT in HR (HRP). External evaluation 2003–2007; Long-term safety and effectiveness of copper-releasing intrauterine devices: a case-study. 2008.spa
dc.relation.referencesReversible L acting, Devices I. Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. 2018;131(735):130–9.spa
dc.relation.referencesfda, cder. ParaGard ® T380A INTRAUTERINE COPPER CONTRACEPTIVE PRESCRIBING INFORMATION ParaGard ® T 380A Intrauterine Copper Contraceptive.spa
dc.relation.referencesDe D, Cruz A, Arteaga M, Castillo L, Tovalin H. Blood copper levels in Mexican users of the T380A IUD. Contraception. 2005;72(2):122–5.spa
dc.relation.referencesStanford JB, Mikolajczyk RT. Mechanisms of action of intrauterine devices: Update and estimation of postfertilization effects. Vol. 187, American Journal of Obstetrics and Gynecology. Mosby Inc.; 2002. p. 1699–708.spa
dc.relation.referencesHeinemann K, Reed S, Moehner S, Do Minh T. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: The European Active Surveillance Study for Intrauterine Devices. Contraception. 2015 Apr 1;91(4):280–3.spa
dc.relation.referencesCwiak C, Cordes S. Postpartum intrauterine device placement: a patient- friendly option. Contracept Reprod Med. 2018;3(1):3–7.spa
dc.relation.referencesSecura, Gina M., PhD, MPH; Allsworth, Jenifer E., PhD; Madden, Tessa, MD, MPH; Mullersman, Jennifer L., BSN; Peipert, Jeffrey F., MD P. The Contraceptive CHOICE Project: Reducing Barriers to LongActing Reversible Contraception. Am J Obstet Gynecol. 2010;203(2):115.spa
dc.relation.referencesAoun J, Dines VA, Gomez-lobo V, Stovall DW, Nelson CB. Effects of Age , Parity , and Device Type on Complications and Discontinuation of Intrauterine Devices. Obstetrics & Gynecology. 2014;123(3):585–92.spa
dc.relation.referencesBerenson AB, Tan A, Hirth JM WGS. Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers. Obstetrics & Gynecology. 2014;121(5):951–8.spa
dc.relation.referencesBerenson AB, Tan A, Hirth JM WGS. Complications and Continuation of Intrauterine Device Use Among Commercially Insured Teenagers. Obstetrics & Gynecology. 2014;121(5):951–8.spa
dc.relation.referencesLuchowski AT, Anderson BL, Power ML, Raglan GB, Espey E, Schulkin J. Obstetrician – Gynecologists and contraception : practice and opinions about the use of IUDs in nulliparous women , adolescents and other. Contraception. 2014;89(6):572–7.spa
dc.relation.referencesTeal SB, Romer SE, Lisa M, Peters MG, Kaplan DW. Insertion Characteristics of Intrauterine Devices in Adolescents and Young Women: Success, Ancillary Measures, and Complications. Am J Obstet Gynecol. 2015;213(4):515.e1-5.spa
dc.relation.referencesCleland K, Raymond EG, Westley E, Trussell J. Emergency contraception review: Evidence-based recommendations for clinicians. Vol. 57, Clinical Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2014. p. 741–50.spa
dc.relation.referencesBahamondes L, Bahamondes MV, Shulman LP. Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Hum Reprod Update. 2015;0(0):1–12.spa
dc.relation.referencesCortessis VK, Barrett M, BrownWade N, Enebish T, Perrigo JL, Tobin J, et al. Intrauterine device use and cervical cancer risk: A systematic review and meta-analysis. In: Obstetrics and Gynecology. Lippincott Williams and Wilkins; 2017. p. 1226–36.spa
dc.relation.referencesGómez Sanchéz PI. Anticoncepcion: Pasado, presente y futuro. Bogotá: Univesidad Nacional de Colombia; 2010.spa
dc.relation.referencesGoldthwaite LM, Cahill EP, Voedisch AJ, Blumenthal PD. Postpartum intrauterine devices: clinical and programmatic review. Am J Obstet Gynecol. 2018;219(3):235–41.spa
dc.relation.referencesChen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: A randomized controlled trial. Obstetrics and Gynecology. 2010;116(5):1079–87.spa
dc.relation.referencesWhitaker AK, Endres LK, Mistretta SQ, Gilliam ML. Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: A randomized controlled trial. Contraception. 2014;89(6):534–9.spa
dc.relation.referencesSonalkar S, Kapp N. Intrauterine device insertion in the postpartum period: A systematic review. European Journal of Contraception and Reproductive Health Care. 2015;20(1):4–18.spa
dc.relation.referencesFarley TMM, Rowe PJ, Meirik O, Rosenberg MJ, Chen JH. Intrauterine devices and pelvic inflammatory disease: an international perspective. The Lancet. 1992 Mar;339(8796):785–8.spa
dc.relation.referencesToivonen J. Intrauterine Contraceptive Device and Pelvic Inflammatory Disease. Ann Med. 1993 Jan 8;25(2):171–3.spa
dc.relation.referencesBorda MR, Winfrey W, McKaig C. Return to sexual activity and modern family planning use in the extended postpartum period: an analysis of findings from seventeen countries. Afr J Reprod Health. 2010;14(4 Spec no.):72–9.spa
dc.relation.referencesBranum AM, Jones J. Trends in long-acting reversible contraception use among U.S. women aged 15-44. NCHS Data Brief. 2015;(188):1–8.spa
dc.relation.referencesZerden ML, Tang JH, Stuart GS, Norton DR, Verbiest SB, Brody S. Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period. Women’s Health Issues. 2015;25(6):616–21.spa
dc.relation.referencesWinner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, et al. Effectiveness of long-acting reversible contraception. Obstet Gynecol Surv. 2012;67(9):552–3.spa
dc.relation.referencesCleland J, Ali M, Benova L, Daniele M. The promotion of intrauterine contraception in low- and middle-income countries: a narrative review. Contraception. 2017;95(6):519–28.spa
dc.relation.referencesPradhan E, Canning D, Shah IH, Puri M, Pearson E, Thapa K, et al. Integrating postpartum contraceptive counseling and IUD insertion services into maternity care in Nepal: Results from stepped-wedge randomized controlled trial. Reprod Health. 2019;16(1):1–15.spa
dc.relation.referencesZapata, Lauren B., PhD; Murtaza, Sarah, MPH; Whiteman, Maura K., PhD; Jamieson, Denise J., MD; Robbins, Cheryl L., PhD; Marchbanks, Polly A., PhD; D’Angelo, Denise V, MPH; Curtis, Kathryn M. PhD. Contraceptive counseling and postpartum contraceptive use. Am J Obstet Gynecol. 2015;212(2):171.spa
dc.relation.referencesHernandez LE, Sappenfield WM, Goodman D, Pooler J. Is effective contraceptive use conceived prenatally in Florida? the association between prenatal contraceptive counseling and postpartum contraceptive use. Matern Child Health J. 2012;16(2):423–9.spa
dc.relation.referencesHarper KD, Loper AC, Louison LM, Morse JE. Stage-based implementation of immediate postpartum long-acting reversible contraception using a reproductive justice framework. Am J Obstet Gynecol. 2020 Apr 1;222(4):S893–905.spa
dc.relation.referencesGeorge IE Eluwa, Ronke Atamewalen, Kingsley Odogwu BA. Success Providing Postpartum Intrauterine Devices in. Glob Health Sci Pract. 2016;4(2):1–6.spa
dc.relation.referencesPleah T, Hyjazi Y, Austin S, Diallo A, Dao B, Waxman R, et al. Increasing use of postpartum family planning and the postpartum IUD: Early experiences in west and central Africa. In: Global Health Science and Practice. Johns Hopkins University Press; 2016. p. S140–52.spa
dc.relation.referencesPfitzer A, Mackenzie D, Blanchard H, Hyjazi Y, Kumar S, Lisanework Kassa S, et al. A facility birth can be the time to start family planning: Postpartum intrauterine device experiences from six countries. International Journal of Gynecology & Obstetrics. 2015 Jun 1;130(S2):S54–61.spa
dc.relation.referencesHuang Y, Merkatz R, Zhu H, Roberts K, Sitruk-Ware R, Cheng L. The free perinatal/postpartum contraceptive services project for migrant women in Shanghai: Effects on the incidence of unintended pregnancy. Contraception. 2014 Jun 1;89(6):521–7.spa
dc.relation.referencesOrtiz-González KM, Benabe E, Rivera-Rosa E, Negrón I, Romaguera J. Knowledge and choices of postpartum contraception among pregnant teens. P R Health Sci J. 2014;33(3):117–21.spa
dc.relation.referencesLopez LM, Hiller JE, Grimes DA, Chen M. Education for contraceptive use by women after childbirth. Cochrane Database of Systematic Reviews. 2012;(8).spa
dc.relation.referencesCommittee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstetrics and gynecology. 2016 Aug;128(2):e32- 7.spa
dc.relation.referencesHuang P, Yao J, Liu X, Luo B. Individualized intervention to improve rates of exclusive breastfeeding. Medicine. 2019 Nov;98(47):e17822.spa
dc.relation.referencesTorres-Cantero AM, Álvarez León EE, Morán-Sánchez I, San Lázaro Campillo I, Bernal Morell E, Hernández Pereña M, et al. El impacto de la pandemia de COVID-19 sobre la salud. Informe SESPAS 2022. Gac Sanit. 2022;36:S4–12.spa
dc.relation.referencesPerez T, Perez RL, Roman J. Conducting Clinical Research in the Era of Covid-19. Am J Med Sci. 2020 Sep;360(3):213–5.spa
dc.relation.referencesAlmufleh A, Joseph J. The time is now: role of pragmatic clinical trials in guiding response to global pandemics. Trials. 2021 Dec 24;22(1):229.spa
dc.relation.referencesBierer BE, White SA, Barnes JM, Gelinas L. Ethical Challenges in Clinical Research During the COVID-19 Pandemic. J Bioeth Inq. 2020 Dec 9;17(4):717–22.spa
dc.relation.referencesMeyer MN, Gelinas L, Bierer BE, Hull SC, Joffe S, Magnus D, et al. An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clinical Trials. 2021 Apr 2;18(2):226–33.spa
dc.relation.referencesMadariaga A, Kasherman L, Karakasis K, Degendorfer P, Heesters AM, Xu W, et al. Optimizing clinical research procedures in public health emergencies. Med Res Rev. 2021 Mar 11;41(2):725–38.spa
dc.relation.uriapolohttps://apolo.unab.edu.co/en/persons/margarita-navarro-rubianospa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.subject.keywordsGynecologyspa
dc.subject.keywordsObstetricsspa
dc.subject.keywordsMedical sciencesspa
dc.subject.keywordsHealth sciencesspa
dc.subject.keywordsColombiaspa
dc.subject.keywordsContraceptionspa
dc.subject.keywordsLong-acting reversible contraceptionspa
dc.subject.keywordsPostpartum periodspa
dc.subject.keywordsIntrauterine devicesspa
dc.subject.keywordsFamily development planningspa
dc.subject.keywordsBirth controlspa
dc.subject.keywordsCopper intrauterine contraceptivesspa
dc.subject.keywordsPostpartum periodspa
dc.subject.lembGinecologíaspa
dc.subject.lembObstetriciaspa
dc.subject.lembCiencias médicasspa
dc.subject.lembControl natalspa
dc.subject.lembAnticonceptivos intrauterinos de cobrespa
dc.subject.lembPeriodo pospartospa
dc.subject.proposalAnticoncepciónspa
dc.subject.proposalPeriodo pospartospa
dc.subject.proposalAnticoncepción reversible de larga duraciónspa
dc.subject.proposalDispositivos intrauterinosspa
dc.subject.proposalPlanificación familiarspa
dc.subject.proposalColombiaspa
dc.subject.proposalCiencias de la saludspa
dc.titleImpacto de un medio audiovisual en la percepción del dispositivo intrauterino tipo T de cobre en el puerperio inmediato en mujeres mayores de edad en el Hospital Local del Norte, Colombiaspa
dc.title.translatedImpact of an audiovisual media on the perception of the copper intrauterine device in the immediate puerperium in women of legal age at the Local del Norte hospital, Colombiaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM

Archivos

Bloque original

Mostrando 1 - 2 de 2
Miniatura
Nombre:
2023_Tesis_Eduardo_Zuñiga.pdf
Tamaño:
906.72 KB
Formato:
Adobe Portable Document Format
Descripción:
Tesis
Descargar
Miniatura
Nombre:
2023_Licencia_Eduardo_Zuñiga.pdf
Tamaño:
569.1 KB
Formato:
Adobe Portable Document Format
Descripción:
Licencia
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
829 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Especialización en Ginecología y Obstetricia